Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the release of new data on the Accelerate Arc Module and BC kit at the 32nd European Congress for Clinical Microbiology and ...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...
New data shows the Accelerate Arc System enables automated and rapid sample preparation that yields robust reportability and accurate microbial id...
New data shows the Accelerate Arc System enables automated and rapid sample preparation that yields robust reportability and accurate microbial identification for positive blood cultures using MALDI...
Analysts predict that Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) will announce earnings per share (EPS) of ($0.32) for the current quarter, according to Zacks. Two analysts have made estimates for Accelerate Diagnostics’ earnings. Accelerate Diagnostics posted earnings per share of ($0.41) in the same quarter last year, which would indicate a positive year-over-year growth […]